ClinicalTrials.govpublic full text
A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235)
diabetes mellitus, type 2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 245446
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.